Company Profile

Home > About CCSB > Company Profile

Chunghwa Chemical Synthesis & Biotech Co. Ltd.,  (CCSB) founded in 1964, is one of the largest API manufacturer in Taiwan, located in the suburb of Taipei with a manufacturing site of 8.7 acres.



CCSB has developed more than 30 bulk pharmaceutical products including Anti-Anxiety agent, Antidiabetics, Laxatives, Antifungals, Antihistamines, Antiseptics, Antiulcerants, Cardiovascular drugs, Skeletal, Muscle relaxants, Hypolipaemics, Antineoplastic, Antihyperlipedemia and Immunosuppresant. In 1984, CCSB was the first pharmaceutical manufacturer in Taiwan inspected and approved by FDA for cGMP compliance. CCSB has filed DMF's for 19 products with the FDA.




In May 2014,CCSB passed again the FDA inspection of their cGMP plant to produce synthesis and biotechnology products.

CCSB has established a sales office, in 1999 Pharmaports LLC in Exton, PA USA to promote its products and provide better services to the North American region. Together, the group has formed an international network providing pharmaceutical ingredients and finished dosages.

CCSB will continuously pursue the goal of quality product, quality service and quality people to become a world-wide major supplier of high quality APIs with competitive prices.

CCSB, as a member of GPhA, actively participates in international generic industry regulatory issues.


Silver Award of Pharmaceutical Manufacture /National Medical and Pharmaceutical Prize of 1998

Award for Industrial Technology Advancement of 1997

Award for Bioindustrial Technology Advancement of 1995

Gold Medal Award for the "Manufacturing Technology" item of the R&D Award of Pharmaceutical Technology 2016

Gold Medal Award for the "Manufacturing Technology" item of the R&D Award of Pharmaceutical Technology 2018



 Contact Infotmation 886-2-8684-3318